Journal article

Modifying the poor prognosis associated with 18FFDG-Avid NET with peptide receptor chemo-radionuclide therapy (PRCRT)

MS Hofman, M Michael, R Kashyap, RJ Hicks

Journal of Nuclear Medicine | Published : 2015

DOI: 10.2967/jnumed.115.154500

University of Melbourne Researchers

Michael Hofman Author

Michael Michael Author

Raghava Kashyap Author

Citation metrics

13Web of Science

Keywords

5.1 Pharmaceuticals

Life Sciences & Biomedicine

Radiology, Nuclear Medicine & Medical Imaging

Endocrine Tumors

Radiation Oncology

Lu-177-Octreotate

Science & Technology

3202 Clinical Sciences

32 Biomedical and Clinical Sciences